Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Sees Large Increase in Short Interest

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) saw a large growth in short interest in the month of August. As of August 14th, there was short interest totaling 82,653 shares, a growth of 51.1% from the July 30th total of 54,710 shares. Based on an average trading volume of 2,525,183 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the company’s shares are sold short.

Advanced Medical Isotope Price Performance

OTCMKTS RDGL opened at $0.05 on Tuesday. The company has a market cap of $25.19 million, a P/E ratio of -5.10 and a beta of -0.73. The stock has a 50-day moving average of $0.06 and a two-hundred day moving average of $0.07. Advanced Medical Isotope has a 1-year low of $0.05 and a 1-year high of $0.12.

Advanced Medical Isotope Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.